Functional and pharmacological properties of human and rat NaV1.8 channels

Neuropharmacology

Volumn 56, Issue 5, 2009, Pages 905-914

  Browne, Liam E ^a   Clare, Jeff J ^b   Wray, Dennis ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Ion Channel Group   (United Kingdom)

Author keywords

Anti nociceptive drugs; Electrophysiology; Ion channels; Sodium channels

Indexed keywords

227C89; 4 (4 FLUOROPHENOXY)BENZALDEHYDE SEMICARBAZONE; 5 (2,6 DICHLOROPHENYL) 6 METHYLPYRIMIDINE 2,4 DIAMINE; 5 (4 CHLOROPHENYL) N (3,5 DIMETHOXYPHENYL) 2 FURANCARBOXAMIDE; A 803467; ANALGESIC AGENT; ANTINOCICEPTIVE AGENT; LAMOTRIGINE; RALFINAMIDE; TETRACAINE; UNCLASSIFIED DRUG; V102862; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG PROTEIN BINDING; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MEMBRANE STEADY POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SODIUM CURRENT; STIMULATION; WHOLE CELL;

ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; CELL LINE; GANGLIA, SPINAL; HUMANS; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; RATS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SPECIES SPECIFICITY;

EID: 63249113812     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.01.018     Document Type: Article

References (41)

1. Abrahamsen B., Zhao J., Asante C.O., Cendan C.M., Marsh S., Martinez-Barbera J.P., Nassar M.A., Dickenson A.H., and Wood J.N. The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 321 (2008) 702-705
2. Akiba I., Seki T., Mori M., Iizuka M., Nishimura S., Sasaki S., Imoto K., and Barsoumian E.L. Stable expression and characterization of human PN1 and PN3 sodium channels. Receptors Channels 9 (2003) 291-299
3. Akopian A.N., Sivilotti L., and Wood J.N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379 (1996) 257-262
4. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dickenson A.H., and Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2 (1999) 541-548
5. 2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22 (2002) 10277-10290
6. V1.8-like sodium channels. Neurosci. Lett. 408 (2006) 129-134
7. Catterall W.A. Molecular mechanisms of gating and drug block of sodium channels. Novartis Found. Symp. 241 (2002) 206-218 discussion 218-232
8. V1.8 in DRG neurons. J. Neurophysiol. 96 (2006) 97-108
9. V1.8. FEBS Lett. 572 (2004) 256-260
10. Condreay J.P., Witherspoon S.M., Clay W.C., and Kost T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 127-132
11. V1.8 expressed in SH-SY5Y neuroblastoma cells. Eur. J. Pharmacol. 528 (2005) 52-58
12. V1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience 146 (2007) 812-821
13. Elliott A.A., and Elliott J.R. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J. Physiol. 463 (1993) 39-56
14. Fitzgerald E.M., Okuse K., Wood J.N., Dolphin A.C., and Moss S.J. cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J. Physiol. 516 Pt 2 (1999) 433-446
15. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 69 (1977) 497-515
16. Hille B. Ionic Channels of Excitable Membranes (2001), Sinauer, Sunderland, MA
17. Ilyin V.I., Hodges D.D., Whittemore E.R., Carter R.B., Cai S.X., and Woodward R.M. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels. Br. J. Pharmacol. 144 (2005) 801-812
18. Jarvis M.F., Honore P., Shieh C.C., Chapman M., Joshi S., Zhang X.F., Kort M., Carroll W., Marron B., Atkinson R., Thomas J., Liu D., Krambis M., Liu Y., McGaraughty S., Chu K., Roeloffs R., Zhong C., Mikusa J.P., Hernandez G., Gauvin D., Wade C., Zhu C., Pai M., Scanio M., Shi L., Drizin I., Gregg R., Matulenko M., Hakeem A., Gross M., Johnson M., Marsh K., Wagoner P.K., Sullivan J.P., Faltynek C.R., and Krafte D.S. A-803467, a potent and selective NaV1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 8520-8525
19. Jeftinija S. The role of tetrodotoxin-resistant sodium channels of small primary afferent fibers. Brain Res. 639 (1994) 125-134
20. V1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology 46 (2004) 425-438
21. V1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain 123 (2006) 75-82
22. Kajander K.C., and Bennett G.J. Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in Aβ and Aδ primary afferent neurons. J. Neurophysiol. 68 (1992) 734-744
23. V1.8 in NGF-induced hyperalgesia, but not neuropathic pain. Neuroreport 12 (2001) 3077-3080
24. Kuo C.C., and Bean B.P. Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol. Pharmacol. 46 (1994) 716-725
25. V1.8. Pain 95 (2002) 143-152
26. V1.8 (SNS/PN3)-null mice. J. Neurosci. 22 (2002) 8352-8356
27. + channels. J. Pharmacol. Exp. Ther. 320 (2007) 354-364
28. Li H.L., Galue A., Meadows L., and Ragsdale D.S. A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel. Mol. Pharmacol. 55 (1999) 134-141
29. Liu G., Yarov-Yarovoy V., Nobbs M., Clare J.J., Scheuer T., and Catterall W.A. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology 44 (2003) 413-422
30. V1.8. Mol. Pain 1 (2005) 24
31. + channels. J. Membr. Biol. 201 (2004) 1-8
32. Porreca F., Lai J., Bian D., Wegert S., Ossipov M.H., Eglen R.M., Kassotakis L., Novakovic S., Rabert D.K., Sangameswaran L., and Hunter J.C. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7640-7644
33. Rabert D.K., Koch B.D., Ilnicka M., Obernolte R.A., Naylor S.L., Herman R.C., Eglen R.M., Hunter J.C., and Sangameswaran L. A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A. Pain 78 (1998) 107-114
34. Renganathan M., Cummins T.R., and Waxman S.G. Contribution of NaV1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86 (2001) 629-640
35. Sangameswaran L., Delgado S.G., Fish L.M., Koch B.D., Jakeman L.B., Stewart G.R., Sze P., Hunter J.C., Eglen R.M., and Herman R.C. Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J. Biol. Chem. 271 (1996) 5953-5956
36. + current heterogeneity in rat nodose neurons and its impact on neuronal discharge. J. Neurophysiol. 78 (1997) 3198-3209
37. + currents in dorsal root ganglion neurons. Eur. J. Pharmacol. 510 (2005) 197-208
38. Ulbricht W. Sodium channel inactivation: molecular determinants and modulation. Physiol. Rev. 85 (2005) 1271-1301
39. V1.8 voltage-gated sodium channel. Biochem. Biophys. Res. Commun. 319 (2004) 531-540
40. Wood J.N., Bevan S.J., Coote P.R., Dunn P.M., Harmar A., Hogan P., Latchman D.S., Morrison C., Rougon G., and Theveniau M. Novel cell lines display properties of nociceptive sensory neurons. Proc. Biol. Sci. 1302 (1990) 187-194
41. Zhao J., Ziane R., Chatelier A., O'leary M.E., and Chahine M. Lidocaine promotes the trafficking and functional expression of Na(v)1.8 sodium channels in mammalian cells. J. Neurophysiol. 98 (2007) 467-477